UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.230

Sortiert nach

Clinical characteristics of hepatocellular carcinoma in patients with cirrhosis: a comparative cohort study

Acta gastro-enterologica belgica, 2023-07, Vol.86 (3), p.412-416

2023

Link zum Volltext

Verfügbarkeit prüfen

5-year mortality of alcohol-related cirrhosis: patients die just as much but not in the same manner

Acta gastro-enterologica belgica, 2022-07, Vol.85 (3), p.447-451

2022

Link zum Volltext

Verfügbarkeit prüfen

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (8), p.1170-1180

2018

Link zum Volltext

Verfügbarkeit prüfen

The changing pattern of cirrhosis in Belgium: a study based on two cohorts prospectively collected 15 years apart

Acta gastro-enterologica belgica, 2020-10, Vol.83 (4), p.559

2020

Link zum Volltext

Verfügbarkeit prüfen

Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study

Endoscopy, 2012-11, Vol.44 (11), p.998

2012

Link zum Volltext

Verfügbarkeit prüfen

Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease

Acta gastro-enterologica belgica, 2022-04, Vol.85 (2), p.321-329

2022

Link zum Volltext

Verfügbarkeit prüfen

Meta-analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients

Alimentary pharmacology & therapeutics, 2012-08, Vol.36 (4), p.353-362

2012

Link zum Volltext

Verfügbarkeit prüfen

Statins and Clarithromycin : a dangerous combination. Case report and review of the literature

Acta gastro-enterologica belgica, 2019-01, Vol.82 (1), p.87-92

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical Features and Outcomes According to the Etiology of Cirrhosis: A 20-Year Follow-Up Study in a Monocentric Cohort

Journal of hepatology, 2016, Vol.64 (2), p.S252-S253

2016

Link zum Volltext

Verfügbarkeit prüfen

Archéologie du bâti. Aujourd’hui et demain

2022

Link zum Volltext

Verfügbarkeit prüfen

Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis

Liver international, 2005-04, Vol.25 (2), p.349-356

2005

Link zum Volltext

Verfügbarkeit prüfen

Decompensated cirrhosis … are we gaining ground?

Acta clinica belgica (English ed. Online), 2013-11, Vol.68 (6), p.411-415

2013

Link zum Volltext

Verfügbarkeit prüfen

HLA association of amoxicillin-clavulanate–induced hepatitis

Gastroenterology (New York, N.Y. 1943), 1999-11, Vol.117 (5), p.1181-1186

1999

Link zum Volltext

Verfügbarkeit prüfen

Interferon-Free, Direct-Acting Antiviral Agents Regimens in Hepatitis C are more Effective, Better Tolerated, and Decrease Fatigue during Treatment in Real-Life Conditions

Journal of hepatology, 2016, Vol.64 (2), p.S743-S743

2016

Link zum Volltext

Verfügbarkeit prüfen

Interferon-Free Treatment of Chronic Hepatitis C with Direct-Acting Antiviral Agents: Age is No Longer an Unfavorable Prognostic Factor

Journal of hepatology, 2016, Vol.64 (2), p.S742-S743

2016

Link zum Volltext

Verfügbarkeit prüfen

Review article: the treatment of non‐alcoholic steatohepatitis with thiazolidinediones

Alimentary pharmacology & therapeutics, 2005-11, Vol.22 (10), p.897-905

2005

Link zum Volltext

Verfügbarkeit prüfen

G08 : Incidence of hepatocellular carcinoma (HCC) and complications in alcoholic compensated cirrhosis. Preliminary results of a multicenter prospective French and belgian cohort (INCA Cirral)

Journal of hepatology, 2015-04, Vol.62, p.S213-S214

2015

Link zum Volltext

Verfügbarkeit prüfen

Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs

Journal of medical virology, 2016-01, Vol.88 (1), p.94-99

2016

Link zum Volltext

Verfügbarkeit prüfen

Anti‐viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy

Alimentary pharmacology & therapeutics, 2011-08, Vol.34 (4), p.454-461

2011

Link zum Volltext

Verfügbarkeit prüfen

Elafibranor, an Agonist of the Peroxisome Proliferator-activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Gastroenterology (New York, N.Y. 1943), 2016-05, Vol.150 (5), p.1147-1159.e5

2016

Link zum Volltext

Verfügbarkeit prüfen

P1111 ANRS HC15 NRFI: LONG-TERM MAINTENANCE THERAPY WITH A COMBINATION OF RIBAVIRIN AND PEGYLATED INTERFERON IN CHRONIC HEPATITIS C. RESULTS OF A MULTICENTER RANDOMIZED CONTROLLED TRIAL

Journal of hepatology, 2014-04, Vol.60 (1), p.S448-S449

2014

Link zum Volltext

Verfügbarkeit prüfen

Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta‐analysis of individual participant data

Hepatology (Baltimore, Md.), 2014-06, Vol.59 (6), p.2170-2177

2014

Link zum Volltext

Verfügbarkeit prüfen

A three-dimensional plasma and energetic particle investigation for the wind spacecraft

Space science reviews, 1995-02, Vol.71 (1-4), p.125-153

1995

Link zum Volltext

Verfügbarkeit prüfen

Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients

Alimentary pharmacology & therapeutics, 2009-08, Vol.30 (4), p.352-363

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical trial: a randomized trial of pegylated‐interferon‐α‐2a plus ribavirin with or without amantadine in treatment‐naïve or relapsing chronic hepatitis C patients

Alimentary pharmacology & therapeutics, 2009-08, Vol.30 (4), p.352-363

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.230

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(905)
Mit Volltextzugriff
(899)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Clinical characteristics of hepatocellular carcinoma in patients with cirrhosis: a comparative cohort study

5-year mortality of alcohol-related cirrhosis: patients die just as much but not in the same manner

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

The changing pattern of cirrhosis in Belgium: a study based on two cohorts prospectively collected 15 years apart

Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study

Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease

Meta-analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients

Statins and Clarithromycin : a dangerous combination. Case report and review of the literature

Clinical Features and Outcomes According to the Etiology of Cirrhosis: A 20-Year Follow-Up Study in a Monocentric Cohort

Archéologie du bâti. Aujourd’hui et demain

Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis

Decompensated cirrhosis … are we gaining ground?

HLA association of amoxicillin-clavulanate–induced hepatitis

Interferon-Free, Direct-Acting Antiviral Agents Regimens in Hepatitis C are more Effective, Better Tolerated, and Decrease Fatigue during Treatment in Real-Life Conditions

Interferon-Free Treatment of Chronic Hepatitis C with Direct-Acting Antiviral Agents: Age is No Longer an Unfavorable Prognostic Factor

Review article: the treatment of non‐alcoholic steatohepatitis with thiazolidinediones

G08 : Incidence of hepatocellular carcinoma (HCC) and complications in alcoholic compensated cirrhosis. Preliminary results of a multicenter prospective French and belgian cohort (INCA Cirral)

Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs

Anti‐viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy

Elafibranor, an Agonist of the Peroxisome Proliferator-activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

P1111 ANRS HC15 NRFI: LONG-TERM MAINTENANCE THERAPY WITH A COMBINATION OF RIBAVIRIN AND PEGYLATED INTERFERON IN CHRONIC HEPATITIS C. RESULTS OF A MULTICENTER RANDOMIZED CONTROLLED TRIAL

Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta‐analysis of individual participant data

A three-dimensional plasma and energetic particle investigation for the wind spacecraft

Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients

Clinical trial: a randomized trial of pegylated‐interferon‐α‐2a plus ribavirin with or without amantadine in treatment‐naïve or relapsing chronic hepatitis C patients

Suchergebnisse filtern